[
pfizer
]Panama to cash in on vaccine tourism after more than 70% locals get shots
Panama plans to open for tourists and offer them vaccines as more than 70% of the population is expected to have two vaccines by next month. Panama initially lagged peers in its vaccination drive but is now among the regional leaders with 56% of its population fully vaccinated
Updated on Sep 23, 2021 07:47 AM IST
Bloomberg | | Posted by Zarafshan Shiraz
Pfizer donates USD 70 million worth Covid-19 treatment drugs to India
Pfizer colleagues at distribution centres in the US, Europe and Asia are hard at work rushing shipments of Pfizer medicines that the Government of India has identified as part of its Covid-19 treatment protocol, the company's Chairman and CEO Albert Bourla said.
Published on May 03, 2021 12:46 PM IST
PTI | , New Delhi
Pfizer's oral medicine for Covid-19 could be ready by next year: CEO
The only antiviral currently approved for use against the coronavirus disease (Covid-19) is Remdesivir, which is manufactured by Gilead Sciences. The US Food and Drug Administration (FDA) gave the drug full approval in October after it was granted emergency use authorization in May last year.
Published on Apr 28, 2021 11:22 AM IST
ANI |
Coronavirus vaccines from Pfizer, BioNTech neutralises Covid-19 Brazil variant
Pfizer has said it believes its current Covid-19 vaccine is highly likely to still protect against the South African variant but is planning to test a third booster dose of it as well as a version retooled specifically to combat the variant in order to better understand the immune response
Updated on Mar 09, 2021 08:23 AM IST
Reuters |
Israel in deal with Pfizer to speed up vaccine deliveries for data
More 1.7 million Israelis, or about 18% of its population, have already received their first dose of the Pfizer-BioNTech vaccine, a larger proportion than in any other country. Officials had warned that pace would slow with new vaccine supplies not expected before February.
Published on Jan 08, 2021 03:41 PM IST
By Bloomberg | Posted by Nilavro Ghosh
News updates from Hindustan Times: Union health minister to visit Tamil Nadu tomorrow to review vaccine dry run in state and all the latest news
Here are today’s top news, analysis, and opinion. Know all about the latest news and other news updates from Hindustan Times.
Updated on Jan 07, 2021 09:16 PM IST
Hindustan Times, New Delhi | By hindustantimes.com
Britain working with Pfizer, AstraZeneca to increase vaccine supplies
More than 1.3 million people in the United Kingdom have received one shot of either AstraZeneca’s or Pfizer’s Covid-19 vaccine, but the government needs to be administering around 2 million doses a week to hit its February target.
Updated on Jan 07, 2021 09:11 PM IST
London | By Reuters | Posted by Mallika Soni
Nearly 20k second doses of Pfizer vaccine given in England before rule change
The figures showed that 19,981 second vaccinations were given between the Dec. 29 and Jan. 3, out of 1.1 million total administered in England. Across the whole of the United Kingdom, 1.3 million doses have been deployed.
Updated on Jan 07, 2021 06:35 PM IST
London | By Reuters| Posted by: Harshit Sabarwal
Timeline: How EU filled its basket in Covid-19 vaccine shopping spree
In June, the EU set up a team of experts from the bloc’s 27 member states to negotiate together with vaccine makers the advance purchase of Covid-19 shots, with a budget of about $2.4 billion.
Published on Jan 06, 2021 07:54 PM IST
Brussels | By Reuters | Posted by Kunal Gaurav
Switzerland says residents who want a Covid-19 shot should get one by summer
Switzerland has ordered a total of about 15 million doses, including from other manufacturers whose products have yet to be approved, after setting aside $455 million to buy shots. High global demand from virtually everywhere, combined with limited production, means there is too little to go around.
Published on Jan 05, 2021 08:52 PM IST
Zurich | By Reuters | Posted by Ayshee Bhaduri
EU seeks up to 300 million more doses of Pfizer-BioNTech Covid-19 vaccine
The new contract would include 100 million doses, as well as an option for as many as 200 million more, said the people.
Published on Jan 05, 2021 07:09 PM IST
By Bloomberg | Posted by Deepali Sharma
Covid-19: UK begins immunisation drive of second vaccine, Mexico okays Oxford-AstraZeneca candidate
Israel has become the third country, after the United States and Canada, to approve Moderna’s Covid-19 vaccine, the American drugmaker said on Monday.
Updated on Jan 05, 2021 08:54 AM IST
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral
Vaccines may not work on South African coronavirus variant: UK scientists
There are currently 60 vaccine candidates in trials, including those that are already being rolled out from AstraZeneca and Oxford, Pfizer and BioNTech, Moderna, Russia’s Sputnik V and China’s Sinopharm.
Published on Jan 05, 2021 07:14 AM IST
London | By Reuters | Posted by Arpan Rai
Video of Egypt virus patients’ ICU death stirs controversy
The governor of Sharqia province denied allegations by a relative of one of the patients that the deaths were caused by a lack of oxygen at the government-run intensive care unit treating Covid-19 patients.
Published on Jan 03, 2021 09:37 PM IST
Cairo | By Associated Press | Posted by Kunal Gaurav
Arvind Kejriwal lauds scientists, doctors after approval to 2 Covid-19 vaccines
The Drugs Controller General of India (DCGI) on Sunday approved Oxford Covid-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country.
Published on Jan 03, 2021 04:00 PM IST
Hindustan Times, New Delhi | By hindustantimes.com| Edited by Susmita Pakrasi
Where are we in the Covid-19 vaccine race?
The World Health Organization on Thursday listed the vaccine for emergency use, in a move seeking to speed access to it in the developing world.
Updated on Jan 03, 2021 02:52 PM IST
By Reuters | Posted by Deepali Sharma
Mexican doctor hospitalized after receiving Covid-19 vaccine
The doctor was admitted to the intensive care unit of a public hospital in the northern state of Nuevo Leon after she experienced seizures, difficulty breathing and a skin rash.
Published on Jan 02, 2021 10:41 PM IST
Mexico City | By Reuters | Posted by Deepali Sharma
Pfizer, BioNTech to offer Covid vaccine to volunteers who got placebo
Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.
Published on Jan 02, 2021 09:10 AM IST
By Reuters | Posted by Nilavro Ghosh
Happy Vaccine Year
An SII official said on Thursday at a webinar that the company had already stockpiled 75 million doses. SII’s chief executive Adar Poonawalla on Wednesday said the company will be supplying India and Covax in a 50-50 manner as and when it produces vials.
Updated on Jan 02, 2021 04:32 AM IST
Hindustan Times, New Delhi | By Rhythma Kaul
BioNTech founders warn of Covid-19 vaccine supply gaps
The German biotech startup has led the vaccine race but its shot has been slow to arrive in the European Union due to relatively slow approval from the bloc’s health regulator and the small size of the order placed by Brussels.
Published on Jan 01, 2021 03:56 PM IST
Berlin | By Reuters | Posted by Ayshee Bhaduri
Covid-19 vaccine update: Pan-India dry run on Saturday, WHO approves Pfizer’s candidate
The European Union (EU) will review a request by Pfizer’s German partner, BioNTech SE, for an additional vaccine dose from each vial, instead of the five currently approved.
Updated on Jan 01, 2021 10:58 AM IST
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Karan Manral
Key expert panel meet today to review data on Serum Institute, Bharat Biotech Covid-19 vaccines
The SEC had met a second time on Wednesday to review their EUA application, after UK’s MHRA granted emergency-use approval to the SII Oxford-AstraZeneca vaccine
Updated on Jan 01, 2021 09:22 AM IST
Hindustan Times, New Delhi | By Rhythma Kaul
From cargo planes to vans: Here’s how Centre plans to distribute Covid-19 vaccine
On Friday, the subject expert committee under the Central Drugs Standard Control Organisation will meet to consider the emergency-use authorisation application of Pfizer, Serum Institute of India (SII) and Bharat Biotech’s Covaxin.
Updated on Jan 01, 2021 08:58 AM IST
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Meenakshi Ray
Elaborate distribution plan on track as India awaits vaccine approval
The vaccines will be stocked at four Government Medical Store Depots (in Karnal, Mumbai, Chennai and Kolkata) and state and regional vaccine stores.
Published on Dec 31, 2020 11:31 PM IST
Hindustan Times, New Delhi | By Saubhadra Chatterji
Shaheen Bagh’s Bilkis Bano is in Gal Gadot’s list of ‘Personal Wonder Women’
The actor, who was recently seen reprising the titular role in “Wonder Woman 1984”, shared a series of pictures on her Instagram page, acknowledging young girls and women from all walks of life across the globe.
Updated on Dec 31, 2020 04:22 PM IST
New Delhi | By Press Trust of India | Posted by Shankhyaneel Sarkar
India likely to start the new year with a Covid vaccine, hints DCGI
The Subject Expert Committee will meet on January 1 to consider the emergency-use authorisation application of Pfizer, Serum Institute of India, and Bharat Biotech’s Covaxin
Updated on Dec 31, 2020 02:42 PM IST
Hindustan Times, New Delhi | By Anonna Dutt
Lessons India can learn from the vaccine rollout in other countries
This provides an opportunity to tweak or overhaul protocols in time
Updated on Dec 31, 2020 05:42 AM IST
UK to follow new immunisation strategy for Oxford-AstraZeneca Covid-19 vaccine. All you need to know
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended inoculating as many people as possible with the first dose before offering others their second dose.
Updated on Dec 30, 2020 08:16 PM IST
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kunal Gaurav
Why AstraZeneca Covid-19 vaccine approval ‘good news for whole world’? UK minister answers
The Phase 3 trials of AstraZeneca’s vaccine across two different dose regimens showed an average efficacy of 70.4%, with no hospitalisations or severe disease observed in the vaccinated groups from three weeks after the first dose.
Updated on Dec 30, 2020 05:18 PM IST
Hindustan Times, New Delhi | By hindustantimes.com | Edited by Kunal Gaurav
New spike in UK cases as Oxford-AstraZeneca vaccine is approved
There were renewed calls for another lockdown and stopping schools from reopening after the holiday period ends in early January, as the number of new day-cases touched 53,135 on Tuesday evening – more than 10 times that of the April-May peak.
Updated on Dec 30, 2020 04:47 PM IST
Hindustan Times, London | By Prasun Sonwalkar , edited by Vinod Janardhanan